The first stop for professional medicines advice

Trusts

60 results

Applied filters

Procurement of unlicensed medicines and other services managed by CMU

12 November 2021Purchasing of medicines is a complex process with many factors to consider

Why is the adverse effect profile of a drug relevant when prescribing for patients with liver disease?

30 October 2020This updated Medicines Q&A summarises the importance of adverse effect profiles of drugs when prescribing for patients with liver dysfunction.

How is acute hypomagnesaemia treated in adults?

12 January 2021There is no national guidance on the treatment of hypomagnesaemia, and practice varies widely between hospital Trusts. The guidance in this document reflects practice at…

What is the Child-Pugh score?

30 October 2020The Child-Pugh score, or the Child-Pugh grade, can be used to describe the clinical state of patients with liver cirrhosis and to assess the severity…

National Homecare Medicines Committee (NHMC) Terms of Reference

5 April 2018National Homecare Medicines Committee (NHMC) The NHMC is a sub group of the National Pharmaceutical Market Supply Group (NPSG) and acts as the national focus…

Procurement Structure

12 November 2021A brief overview of collaborative working for procurement of medicines and pharmaceutical products and services in the NHS.

Doctors, dentists, and use of PGDs

15 December 2020Doctors and dentists cannot supply or administer medications under a PGD or Written Instruction.  This page gives further detail on why this is the case.

Risk assessing transcribing for administration

22 February 2022Various factors affect the risks associated with using transcribing for medicines administration.

Patient Group Direction use in Hospital at Home, including virtual ward, services

28 March 2023Considerations required before implementing Patient Group Direction (PGDs) in Hospital at Home, including virtual ward, services

Using medicines under PGD as part of a clinical trial or study

26 June 2019Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot